tiprankstipranks
Siemens Healthineers (CH:SHL)
OTHER OTC:SHL
Switzerland Market
SHL
Siemens Healthineers AG
RESEARCH TOOLSreports

Siemens Healthineers AG (SHL) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

SHL Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
8 Buy
4 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Siemens
Healthineers AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SHL Stock 12 Month Forecast

Average Price Target

CHF44.39
▲(27.37% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Siemens Healthineers AG in the last 3 months. The average price target is CHF44.39 with a high forecast of CHF51.47 and a low forecast of CHF34.13. The average price target represents a 27.37% change from the last price of CHF34.85.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"30":"CHF30","41":"CHF41","52":"CHF52","35.5":"CHF35.5","46.5":"CHF46.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":51.467753286,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF51.47</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":44.38863130625,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF44.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.12736329,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF34.13</span>\n  </div></div>","useHTML":true}}],"tickPositions":[30,35.5,41,46.5,52],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.46,32.99905794507692,34.53811589015385,36.07717383523077,37.61623178030769,39.15528972538461,40.69434767046154,42.23340561553846,43.772463560615385,45.311521505692305,46.85057945076923,48.38963739584615,49.92869534092307,{"y":51.467753286,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.46,32.45451010048077,33.44902020096154,34.44353030144231,35.438040401923075,36.43255050240384,37.427060602884616,38.42157070336538,39.41608080384616,40.410590904326924,41.40510100480769,42.39961110528846,43.39412120576923,{"y":44.38863130625,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.46,31.665181791538462,31.870363583076923,32.07554537461539,32.280727166153845,32.48590895769231,32.69109074923077,32.89627254076923,33.10145433230769,33.306636123846154,33.51181791538461,33.716999706923076,33.92218149846154,{"y":34.12736329,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":42.981,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.981,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.981,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.981,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.981,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.981,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.981,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.981,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.981,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.89,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.7,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.77,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.46,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF51.47Average Price TargetCHF44.39Lowest Price TargetCHF34.13
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CH:SHL
Julien Dormois
Jefferies
Jefferies
CHF46.12
Buy
32.33%
Upside
Reiterated
06/25/26
Siemens Healthineers AG (SEMHF) Receives a Buy from Jefferies
Morgan Stanley Analyst forecast on CH:SHL
Aisyah Noor
Morgan Stanley
Morgan Stanley
CHF37.82→CHF34.13
Hold
-2.07%
Downside
Reiterated
06/23/26
Siemens Healthineers price target lowered to EUR 37 at Morgan StanleySiemens Healthineers price target lowered to EUR 37 at Morgan Stanley
Barclays Analyst forecast on CH:SHL
Hassan Al-Wakeel
Barclays
Barclays
CHF46.12
Buy
32.33%
Upside
Reiterated
05/22/26
Barclays Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)
Deutsche Bank Analyst forecast on CH:SHL
Falko Friedrichs
Deutsche Bank
Deutsche Bank
CHF38.74→CHF35.05
Hold
0.57%
Upside
Reiterated
05/15/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF), Tarsus Pharmaceuticals (NASDAQ: TARS) and Jasper Therapeutics (NASDAQ: JSPR)
Bernstein Analyst forecast on CH:SHL
Susannah Ludwig
Bernstein
Bernstein
CHF48.1→CHF42.15
Buy
20.95%
Upside
Reiterated
05/12/26
Bernstein Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)
J.P. Morgan Analyst forecast on CH:SHL
David Adlington
J.P. Morgan
J.P. Morgan
CHF56.54→CHF51.47
Buy
47.68%
Upside
Reiterated
05/12/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Siemens Healthineers AG (Other OTC: SEMHF) and BioNTech SE (NASDAQ: BNTX)
Goldman Sachs Analyst forecast on CH:SHL
Richard Felton
Goldman Sachs
Goldman Sachs
CHF41.51→CHF38.74
Hold
11.16%
Upside
Reiterated
05/11/26
Goldman Sachs Remains a Hold on Siemens Healthineers AG (SEMHF)
Kepler Capital Analyst forecast on CH:SHL
Oliver Reinberg
Kepler Capital
Kepler Capital
CHF45.2→CHF42.43
Buy
21.75%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Sandoz Group Ltd (Other OTC: SDZXF)
RBC Capital Analyst forecast on CH:SHL
Natalia Webster
RBC Capital
RBC Capital
CHF50.73
Buy
45.57%
Upside
Reiterated
05/07/26
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (NASDAQ: ACAD) and Siemens Healthineers AG (Other OTC: SEMHF)
UBS Analyst forecast on CH:SHL
Graham Doyle
UBS
UBS
CHF47.04
Hold
34.98%
Upside
Reiterated
05/07/26
Siemens Healthineers AG (SEMHF) Receives a Hold from UBS
Berenberg Bank Analyst forecast on CH:SHL
Sam England
Berenberg Bank
Berenberg Bank
CHF49.81
Buy
42.92%
Upside
Reiterated
05/07/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medline (NASDAQ: MDLN), QuidelOrtho (NASDAQ: QDEL) and Siemens Healthineers AG (Other OTC: SEMHF)
Citi Analyst forecast on CH:SHL
Veronika Dubajova
Citi
Citi
CHF54.42→CHF48.89
Buy
40.27%
Upside
Reiterated
04/22/26
Siemens Healthineers price target lowered to EUR 53 from EUR 59 at CitiSiemens Healthineers price target lowered to EUR 53 from EUR 59 at Citi
DZ BANK AG Analyst forecast on CH:SHL
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
03/09/26
DZ BANK AG Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
DBS Analyst forecast on CH:SHL
Nico Chen
DBS
DBS
CHF47.96
Buy
37.63%
Upside
Reiterated
02/24/26
DBS Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)
Exane BNP Paribas Analyst forecast on CH:SHL
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
CHF44.27
Hold
27.04%
Upside
Downgraded
12/10/25
Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on CH:SHL
Julien Dormois
Jefferies
Jefferies
CHF46.12
Buy
32.33%
Upside
Reiterated
06/25/26
Siemens Healthineers AG (SEMHF) Receives a Buy from Jefferies
Morgan Stanley Analyst forecast on CH:SHL
Aisyah Noor
Morgan Stanley
Morgan Stanley
CHF37.82→CHF34.13
Hold
-2.07%
Downside
Reiterated
06/23/26
Siemens Healthineers price target lowered to EUR 37 at Morgan StanleySiemens Healthineers price target lowered to EUR 37 at Morgan Stanley
Barclays Analyst forecast on CH:SHL
Hassan Al-Wakeel
Barclays
Barclays
CHF46.12
Buy
32.33%
Upside
Reiterated
05/22/26
Barclays Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)
Deutsche Bank Analyst forecast on CH:SHL
Falko Friedrichs
Deutsche Bank
Deutsche Bank
CHF38.74→CHF35.05
Hold
0.57%
Upside
Reiterated
05/15/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF), Tarsus Pharmaceuticals (NASDAQ: TARS) and Jasper Therapeutics (NASDAQ: JSPR)
Bernstein Analyst forecast on CH:SHL
Susannah Ludwig
Bernstein
Bernstein
CHF48.1→CHF42.15
Buy
20.95%
Upside
Reiterated
05/12/26
Bernstein Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)
J.P. Morgan Analyst forecast on CH:SHL
David Adlington
J.P. Morgan
J.P. Morgan
CHF56.54→CHF51.47
Buy
47.68%
Upside
Reiterated
05/12/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Siemens Healthineers AG (Other OTC: SEMHF) and BioNTech SE (NASDAQ: BNTX)
Goldman Sachs Analyst forecast on CH:SHL
Richard Felton
Goldman Sachs
Goldman Sachs
CHF41.51→CHF38.74
Hold
11.16%
Upside
Reiterated
05/11/26
Goldman Sachs Remains a Hold on Siemens Healthineers AG (SEMHF)
Kepler Capital Analyst forecast on CH:SHL
Oliver Reinberg
Kepler Capital
Kepler Capital
CHF45.2→CHF42.43
Buy
21.75%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Sandoz Group Ltd (Other OTC: SDZXF)
RBC Capital Analyst forecast on CH:SHL
Natalia Webster
RBC Capital
RBC Capital
CHF50.73
Buy
45.57%
Upside
Reiterated
05/07/26
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (NASDAQ: ACAD) and Siemens Healthineers AG (Other OTC: SEMHF)
UBS Analyst forecast on CH:SHL
Graham Doyle
UBS
UBS
CHF47.04
Hold
34.98%
Upside
Reiterated
05/07/26
Siemens Healthineers AG (SEMHF) Receives a Hold from UBS
Berenberg Bank Analyst forecast on CH:SHL
Sam England
Berenberg Bank
Berenberg Bank
CHF49.81
Buy
42.92%
Upside
Reiterated
05/07/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medline (NASDAQ: MDLN), QuidelOrtho (NASDAQ: QDEL) and Siemens Healthineers AG (Other OTC: SEMHF)
Citi Analyst forecast on CH:SHL
Veronika Dubajova
Citi
Citi
CHF54.42→CHF48.89
Buy
40.27%
Upside
Reiterated
04/22/26
Siemens Healthineers price target lowered to EUR 53 from EUR 59 at CitiSiemens Healthineers price target lowered to EUR 53 from EUR 59 at Citi
DZ BANK AG Analyst forecast on CH:SHL
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
03/09/26
DZ BANK AG Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
DBS Analyst forecast on CH:SHL
Nico Chen
DBS
DBS
CHF47.96
Buy
37.63%
Upside
Reiterated
02/24/26
DBS Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)
Exane BNP Paribas Analyst forecast on CH:SHL
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
CHF44.27
Hold
27.04%
Upside
Downgraded
12/10/25
Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Siemens Healthineers AG

3 Months
Julien DormoisJefferies
Success Rate
10/26 ratings generated profit
38%
Average Return
-1.58%
Copying Julien Dormois's trades and holding each position for 3 Months would result in 38.46% of your transactions generating a profit, with an average return of -1.58% per trade.
1 Year
Hassan Al-WakeelBarclays
Success Rate
11/35 ratings generated profit
31%
Average Return
-5.03%
Copying Hassan Al-Wakeel's trades and holding each position for 1 Year would result in 31.43% of your transactions generating a profit, with an average return of -5.03% per trade.
2 Years
David AdlingtonJ.P. Morgan
Success Rate
20/59 ratings generated profit
34%
Average Return
-11.47%
Copying David Adlington's trades and holding each position for 2 Years would result in 33.90% of your transactions generating a profit, with an average return of -11.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHL Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
2
4
11
9
Buy
21
22
20
15
10
Hold
9
7
7
8
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
31
31
34
27
In the current month, SHL has received 19 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. SHL average Analyst price target in the past 3 months is 44.39.
Each month's total comprises the sum of three months' worth of ratings.

SHL Financial Forecast

SHL Earnings Forecast

Next quarter’s earnings estimate for SHL is CHF0.52 with a range of CHF0.50 to CHF0.55. The previous quarter’s EPS was CHF0.49. SHL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.
Next quarter’s earnings estimate for SHL is CHF0.52 with a range of CHF0.50 to CHF0.55. The previous quarter’s EPS was CHF0.49. SHL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.

SHL Sales Forecast

Next quarter’s sales forecast for SHL is CHF5.18B with a range of CHF4.37B to CHF5.42B. The previous quarter’s sales results were CHF5.24B. SHL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.
Next quarter’s sales forecast for SHL is CHF5.18B with a range of CHF4.37B to CHF5.42B. The previous quarter’s sales results were CHF5.24B. SHL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.

SHL Stock Forecast FAQ

What is CH:SHL’s average 12-month price target, according to analysts?
Based on analyst ratings, Siemens Healthineers’s 12-month average price target is 44.39.
    What is CH:SHL’s upside potential, based on the analysts’ average price target?
    Siemens Healthineers has 27.37% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Siemens Healthineers a Buy, Sell or Hold?
          Siemens Healthineers has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 4 hold ratings and 0 sell ratings.
            What is Siemens Healthineers’s share price target?
            The average share price target for Siemens Healthineers is 44.39. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF51.47 ,and the lowest forecast is CHF34.13. The average share price target represents 27.37% Increase from the current price of CHF34.85.
              What do analysts say about Siemens Healthineers?
              Siemens Healthineers’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Siemens Healthineers?
                To buy shares of CH:SHL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.